iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
Hallek, Michael, Cheson, Bruce D., Catovsky, Daniel, Caligaris-Cappio, Federico, Dighiero, Guillermo, Döhner, Hartmut, Hillmen, Peter, Keating, Michael, Montserrat, Emili, Chiorazzi, Nicholas, Stilgenbauer, Stephan, Rai, Kanti R., Byrd, John C., Eichhorst, Barbara, O'Brien, Susan, Robak, Tadeusz, Seymour, John F., Kipps, Thomas J.
Published in Blood (21.06.2018)
Published in Blood (21.06.2018)
Get full text
Journal Article
Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab
Seymour, John F., Kipps, Thomas J., Eichhorst, Barbara F., D'Rozario, James, Owen, Carolyn J., Assouline, Sarit, Lamanna, Nicole, Robak, Tadeusz, de la Serna, Javier, Jaeger, Ulrich, Cartron, Guillaume, Montillo, Marco, Mellink, Clemens, Chyla, Brenda, Panchal, Anesh, Lu, Tong, Wu, Jenny Q., Jiang, Yanwen, Lefebure, Marcus, Boyer, Michelle, Kater, Arnon P.
Published in Blood (25.08.2022)
Published in Blood (25.08.2022)
Get full text
Journal Article
Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
Seymour, John F, Kipps, Thomas J, Eichhorst, Barbara, Hillmen, Peter, D’Rozario, James, Assouline, Sarit, Owen, Carolyn, Gerecitano, John, Robak, Tadeusz, De la Serna, Javier, Jaeger, Ulrich, Cartron, Guillaume, Montillo, Marco, Humerickhouse, Rod, Punnoose, Elizabeth A, Li, Yan, Boyer, Michelle, Humphrey, Kathryn, Mobasher, Mehrdad, Kater, Arnon P
Published in The New England journal of medicine (22.03.2018)
Published in The New England journal of medicine (22.03.2018)
Get full text
Journal Article
Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study
Kater, Arnon P, Seymour, John F, Hillmen, Peter, Eichhorst, Barbara, Langerak, Anton W, Owen, Carolyn, Verdugo, Maria, Wu, Jenny, Punnoose, Elizabeth A, Jiang, Yanwen, Wang, Jue, Boyer, Michelle, Humphrey, Kathryn, Mobasher, Mehrdad, Kipps, Thomas J
Published in Journal of clinical oncology (01.02.2019)
Published in Journal of clinical oncology (01.02.2019)
Get full text
Journal Article
Sequential and combination treatments with novel agents in chronic lymphocytic leukemia
Fürstenau, Moritz, Hallek, Michael, Eichhorst, Barbara
Published in Haematologica (Roma) (01.11.2019)
Published in Haematologica (Roma) (01.11.2019)
Get full text
Journal Article
Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables
Roberts, Andrew W., Ma, Shuo, Kipps, Thomas J., Coutre, Steven E., Davids, Matthew S., Eichhorst, Barbara, Hallek, Michael, Byrd, John C., Humphrey, Kathryn, Zhou, Lang, Chyla, Brenda, Nielsen, Jacqueline, Potluri, Jalaja, Kim, Su Young, Verdugo, Maria, Stilgenbauer, Stephan, Wierda, William G., Seymour, John F.
Published in Blood (11.07.2019)
Published in Blood (11.07.2019)
Get full text
Journal Article
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
Stilgenbauer, Stephan, Prof, Eichhorst, Barbara, Prof, Schetelig, Johannes, Prof, Coutre, Steven, Prof, Seymour, John F, Prof, Munir, Talha, Prof, Puvvada, Soham D, MD, Wendtner, Clemens-Martin, Prof, Roberts, Andrew W, Prof, Jurczak, Wojciech, Prof, Mulligan, Stephen P, Prof, Böttcher, Sebastian, MD, Mobasher, Mehrdad, MD, Zhu, Ming, PhD, Desai, Monali, MD, Chyla, Brenda, PhD, Verdugo, Maria, MD, Enschede, Sari Heitner, MD, Cerri, Elisa, MD, Humerickhouse, Rod, MD, Gordon, Gary, MD, Hallek, Michael, Prof, Wierda, William G, MD
Published in The lancet oncology (01.06.2016)
Published in The lancet oncology (01.06.2016)
Get full text
Journal Article
Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial
BÖTTCHER, Sebastian, RITGEN, Matthias, MENDILA, Myriam, WENDTNER, Clemens-Martin, EICHHORST, Barbara F, DÖHNER, Hartmut, HALLEK, Michael J, KNEBA, Michael, FISCHER, Kirsten, STILGENBAUER, Stephan, BUSCH, Raymonde M, FINGERLE-ROWSON, Günter, FINK, Anna Maria, BÜHLER, Andreas, ZENZ, Thorsten, WENGER, Michael Karl
Published in Journal of clinical oncology (20.03.2012)
Published in Journal of clinical oncology (20.03.2012)
Get full text
Journal Article
Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study
Kater, Arnon P, Wu, Jenny Qun, Kipps, Thomas, Eichhorst, Barbara, Hillmen, Peter, D'Rozario, James, Assouline, Sarit, Owen, Carolyn, Robak, Tadeusz, de la Serna, Javier, Jaeger, Ulrich, Cartron, Guillaume, Montillo, Marco, Dubois, Julie, Eldering, Eric, Mellink, Clemens, Van Der Kevie-Kersemaekers, Anne-Marie, Kim, Su Young, Chyla, Brenda, Punnoose, Elizabeth, Bolen, Christopher R, Assaf, Zoe June, Jiang, Yanwen, Wang, Jue, Lefebure, Marcus, Boyer, Michelle, Humphrey, Kathryn, Seymour, John F
Published in Journal of clinical oncology (01.12.2020)
Published in Journal of clinical oncology (01.12.2020)
Get full text
Journal Article
Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
FISCHER, Kirsten, CRAMER, Paula, KRANZ, Gabriele, GOEDE, Valentin, ELTER, Thomas, BÜHLER, Andreas, WINKLER, Dirk, KNEBA, Michael, DÖHNER, Hartmut, EICHHORST, Barbara F, HALLEK, Michael, WENDTNER, Clemens-Martin, BUSCH, Raymonde, STILGENBAUER, Stephan, BAHLO, Jasmin, SCHWEIGHOFER, Carmen D, BOTTCHER, Sebastian, STAIB, Peter, KIEHL, Michael, ECKART, Michael J
Published in Journal of clinical oncology (10.09.2011)
Published in Journal of clinical oncology (10.09.2011)
Get full text
Journal Article
Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
FISCHER, Kirsten, CRAMER, Paula, TRESCKOW, Julia Von, FINK, Anna-Maria, BÜHLER, Andreas, WINKLER, Dirk, KREUZER, Karl-Anton, STAIB, Peter, RITGEN, Matthias, KNEBA, Michael, DÖHNER, Hartmut, EICHHORST, Barbara F, BUSCH, Raymonde, HALLEK, Michael, STILGENBAUER, Stephan, WENDTNER, Clemens-Martin, BÖTTCHER, Sebastian, BAHLO, Jasmin, SCHUBERT, Jöerg, PFLÜGER, Karl H, SCHOTT, Silke, GOEDE, Valentin, ISFORT, Susanne
Published in Journal of clinical oncology (10.09.2012)
Published in Journal of clinical oncology (10.09.2012)
Get full text
Journal Article
Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia
Pflug, Natali, Bahlo, Jasmin, Shanafelt, Tait D., Eichhorst, Barbara F., Bergmann, Manuela A., Elter, Thomas, Bauer, Kathrin, Malchau, Gebhart, Rabe, Kari G., Stilgenbauer, Stephan, Döhner, Hartmut, Jäger, Ulrich, Eckart, Michael J., Hopfinger, Georg, Busch, Raymonde, Fink, Anna-Maria, Wendtner, Clemens-Martin, Fischer, Kirsten, Kay, Neil E., Hallek, Michael
Published in Blood (03.07.2014)
Published in Blood (03.07.2014)
Get full text
Journal Article
TP53 Mutation and Survival in Chronic Lymphocytic Leukemia
ZENZ, Thorsten, EICHHORST, Barbara, HENSEL, Manfred, HALLEK, Michael, DÖHNER, Hartmut, STILGENBAUER, Stephan, BUSCH, Raymonde, DENZEL, Tina, HÄBE, Sonja, WINKLER, Dirk, BÜHLER, Andreas, EDELMANN, Jennifer, BERGMANN, Manuela, HOPFINGER, Georg
Published in Journal of clinical oncology (10.10.2010)
Published in Journal of clinical oncology (10.10.2010)
Get full text
Journal Article
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
Al-Sawaf, Othman, Zhang, Can, Jin, Hyun Yong, Robrecht, Sandra, Choi, Yoonha, Balasubramanian, Sandhya, Kotak, Alex, Chang, Yi Meng, Fink, Anna Maria, Tausch, Eugen, Schneider, Christof, Ritgen, Matthias, Kreuzer, Karl-Anton, Chyla, Brenda, Paulson, Joseph N., Pallasch, Christian P., Frenzel, Lukas P., Peifer, Martin, Eichhorst, Barbara, Stilgenbauer, Stephan, Jiang, Yanwen, Hallek, Michael, Fischer, Kirsten
Published in Nature communications (18.04.2023)
Published in Nature communications (18.04.2023)
Get full text
Journal Article
CLL2-BIG: sequential treatment with bendamustine, ibrutinib and obinutuzumab (GA101) in chronic lymphocytic leukemia
von Tresckow, Julia, Cramer, Paula, Bahlo, Jasmin, Robrecht, Sandra, Langerbeins, Petra, Fink, Anna-Maria, Al-Sawaf, Othman, Illmer, Thomas, Klaproth, Holger, Estenfelder, Sven, Ritgen, Matthias, Fischer, Kirsten, Wendtner, Clemens-Martin, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Böttcher, Sebastian, Eichhorst, Barbara F., Hallek, Michael
Published in Leukemia (01.05.2019)
Published in Leukemia (01.05.2019)
Get full text
Journal Article
Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG)
Jaramillo, Sonia, Agathangelidis, Andreas, Schneider, Christof, Bahlo, Jasmin, Robrecht, Sandra, Tausch, Eugen, Bloehdorn, Johannes, Hoechstetter, Manuela, Fischer, Kirsten, Eichhorst, Barbara, Goede, Valentin, Hallek, Michael, Döhner, Hartmut, Rosenquist, Richard, Ghia, Paolo, Stamatopoulos, Kostas, Stilgenbauer, Stephan
Published in Haematologica (Roma) (01.11.2020)
Published in Haematologica (Roma) (01.11.2020)
Get full text
Journal Article
Venetoclax and obinutuzumab in chronic lymphocytic leukemia
Fischer, Kirsten, Al-Sawaf, Othman, Fink, Anna-Maria, Dixon, Mark, Bahlo, Jasmin, Warburton, Simon, Kipps, Thomas J., Weinkove, Robert, Robinson, Sue, Seiler, Till, Opat, Stephen, Owen, Carolyn, López, Javier, Humphrey, Kathryn, Humerickhouse, Rod, Tausch, Eugen, Frenzel, Lukas, Eichhorst, Barbara, Wendtner, Clemens-M., Stilgenbauer, Stephan, Langerak, Anton W., van Dongen, Jacque J.M., Böttcher, Sebastian, Ritgen, Matthias, Goede, Valentin, Mobasher, Mehrdad, Hallek, Michael
Published in Blood (11.05.2017)
Published in Blood (11.05.2017)
Get full text
Journal Article
ALPINE: zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma
Hillmen, Peter, Brown, Jennifer R, Eichhorst, Barbara F, Lamanna, Nicole, O'Brien, Susan M, Qiu, Lugui, Salmi, Tommi, Hilger, James, Wu, Kenneth, Cohen, Aileen, Huang, Jane, Tam, Constantine S
Published in Future oncology (London, England) (01.04.2020)
Published in Future oncology (London, England) (01.04.2020)
Get full text
Journal Article
A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL
Dimier, Natalie, Delmar, Paul, Ward, Carol, Morariu-Zamfir, Rodica, Fingerle-Rowson, Günter, Bahlo, Jasmin, Fischer, Kirsten, Eichhorst, Barbara, Goede, Valentin, van Dongen, Jacques J.M., Ritgen, Matthias, Böttcher, Sebastian, Langerak, Anton W., Kneba, Michael, Hallek, Michael
Published in Blood (01.03.2018)
Published in Blood (01.03.2018)
Get full text
Journal Article
First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia
Eichhorst, Barbara F., Busch, Raymonde, Stilgenbauer, Stephan, Stauch, Martina, Bergmann, Manuela A., Ritgen, Matthias, Kranzhöfer, Nicole, Rohrberg, Robert, Söling, Ulrike, Burkhard, Oswald, Westermann, Anne, Goede, Valentin, Schweighofer, Carmen D., Fischer, Kirsten, Fink, Anna-Maria, Wendtner, Clemens M., Brittinger, Günter, Döhner, Hartmut, Emmerich, Bertold, Hallek, Michael
Published in Blood (15.10.2009)
Published in Blood (15.10.2009)
Get full text
Journal Article